Evidence map›Paper›PMID 42633372›Full record

ArticleADMET & DMPK2026

Prediction of bile salt export pump inhibition using biomimetic chromatographic descriptors: Integrating membrane affinity and protein binding.

Chrysanthos Stergiopoulos, Klara Valko

Abstract read
In one paragraph

Article in ADMET & DMPK, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Chrysanthos StergiopoulosLaboratory of Process Analysis and Design, School of Chemical Engineering, National Technical University of Athens, Iroon Polytechniou 9, 157 75 Zografou, Athens, Greece.ORCID https://orcid.org/0000-0001-6002-4870
Klara ValkoBio-Mimetic Chromatography Ltd, Business & Technology Centre, Bessemer Drive, Stevenage, Herts, SG1 2DX, United Kingdom.ORCID https://orcid.org/0000-0003-4605-2941

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose: Bile salt export pump (BSEP) inhibition is a key mechanistic driver of cholestatic drug-induced liver injury, yet current prediction approaches rely mainly on in vitro potency and calculated physicochemical descriptors that do not adequately reflect local exposure at the canalicular membrane. This study aimed to evaluate whether biomimetic chromatographic descriptors could improve predictions of BSEP inhibition by incorporating mechanistically relevant information on membrane affinity and protein binding. Experimental approach: A dataset of 62 structurally diverse compounds with reported BSEP inhibition data was compiled and modelled using multiple linear regression. Biomimetic descriptors derived from immobilized artificial membrane chromatography and human serum albumin affinity (log Key results: Models based on biomimetic descriptors demonstrated superior, more balanced predictive performance than conventional physicochemical models, with greater robustness and external predictivity. The combination of membrane-affinity and protein-binding descriptors provided a more accurate representation of the determinants governing BSEP interactions. Conclusion: Biomimetic chromatographic descriptors provide an experimentally grounded approximation of membrane-proximal exposure, a key determinant of BSEP interactions that conventional descriptors do not capture. This approach extends beyond traditional quantitative structure-activity relationship by incorporating distribution-relevant properties into predictive modelling and offers a simple, interpretable framework to support early identification of transporter-mediated toxicity risk in drug discovery.

Indexed as

canalicular transportdrug distributionHepatotoxicitypredictive modellingtransporter inhibition

Identifiers

PMID42633372
PMCPMC13499664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.